scholarly journals Critical Review of Alcohol, Alcoholism and the Withdrawal Symptoms. II. Treatment Strategies

2017 ◽  
Vol 1 (1) ◽  
Author(s):  
K Singh Ashok
2020 ◽  
Vol 35 ◽  
pp. 101232 ◽  
Author(s):  
Pallvi Bhanot ◽  
S. Mary Celin ◽  
T.R. Sreekrishnan ◽  
Anchita Kalsi ◽  
S.K. Sahai ◽  
...  

2017 ◽  
Vol 50 (03) ◽  
pp. 87-95 ◽  
Author(s):  
Norbert Wodarz ◽  
Anne Krampe-Scheidler ◽  
Michael Christ ◽  
Heribert Fleischmann ◽  
Winfried Looser ◽  
...  

AbstractConsumption of methamphetamine (“crystal”) has spread dramatically over several European countries. The management of methamphetamine-induced acute disorders has become a growing challenge to the health system. Pharmacological treatment strategies for methamphetamine-induced intoxication syndromes, acute withdrawal symptoms, and methamphetamine-induced psychosis are particularly important.The development of interdisciplinary and evidence- and consensus-based (S3) German Guidelines was based on a systematic literature and guideline search on therapeutic interventions in methamphetamine-related disorders (April, June 2015). Consideration was given to 9 guidelines and 103 publications. Recommendations on pharmacological treatment strategies were drawn up using the nominal group technique.Overall, only limited evidence is available. Benzodiazepines are first-line medication for methamphetamine-induced intoxication syndromes, particularly when they present with acute agitation and aggressive behavior. There is no evidence-based medication for the treatment of methamphetamine-related withdrawal symptoms and cravings. When treating methamphetamine-induced psychosis, second-generation antipsychotics should be favored, given their more favorable side-effect profile. The indication for continuation of antipsychotic medication must be reviewed regularly. In most cases, the antipsychotic should be tapered off within 6 months.


2003 ◽  
Vol 21 (11) ◽  
pp. 2199-2210 ◽  
Author(s):  
Simon Wilkinson ◽  
Gerald W. Chodak

Despite its prominence as the most frequently diagnosed solid tumor among men in the United States, relatively little is known about the etiology of prostate cancer. Furthermore, research into treatment strategies for prostate cancer continues to lag behind research for the other most common cancers. At the same time, however, the popularity of complementary therapies among prostate cancer patients continues to grow. In this article, we provide a critical review of the most recent evidence for dietary modifications, food supplements, and herbs in prostate cancer prevention and treatment. Despite encouraging data for some of these interventions, even the strongest proponents of complementary therapy agree that only randomized controlled trials can provide sufficient evidence on which to create universal guidelines. However, such trials are highly complex and expensive, and they require lengthy follow-up. Until such trials are completed, an opportunity exists for health care professionals to improve their knowledge and understanding of the current evidence for or against complementary therapy in prostate cancer.


2019 ◽  
Vol 160 ◽  
pp. 94-109 ◽  
Author(s):  
G. Janet Joshiba ◽  
P. Senthil Kumar ◽  
Carolin C. Femina ◽  
Eunice Jayashree ◽  
R. Racchana ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document